Johnson & Johnson posted stronger-than-expected earnings and raised its full-year outlook

The healthcare company posted $25.31 billion in quarterly sales and raised its annual sales forecast to about $101.1 billion at the midpoint

Jeff Schear / Getty Images

Johnson & Johnson $JNJ reported second-quarter sales of $25.31 billion on Wednesday, up 6.6% from a year earlier, as strong demand for drugs in its Innovative Medicine segment helped the company top expectations and lift its full-year guidance.

On a per-share basis, adjusted earnings were $2.90, a 4.7% improvement over the year-ago quarter, clearing the consensus estimate of $2.85, with revenue also surpassing the........

© Quartz